OverviewChartNewsTraderScreen

Goldman Sachs Discount Zert BAYN .../  DE000GG5PVM3  /

EUWAX
10/01/2025  14:09:17 Chg.+0.61 Bid18:25:40 Ask18:25:40 Underlying Strike price Expiration date Option type
20.23EUR +3.11% 19.84
Bid Size: 10,000		 -
Ask Size: -		 BAYER AG NA O.N. - EUR 25/03/2025 Call
TeleTrader 12/11/2024 Bayer dips 12%, hits 20-year low after earnings report
TeleTrader 12/11/2024 Bayer's sales in Q3 down 3.6% to €9.9 billion
TeleTrader 16/08/2024 Bayer jumps 10% after Roundup court win
GlobeNewswire 02/08/2024 Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting A...
GlobeNewswire 11/07/2024 AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational...
GlobeNewswire 25/06/2024 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 30/05/2024 Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire 30/05/2024 BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire 29/05/2024 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
GlobeNewswire 28/05/2024 Pairwise and Bayer Expand CRISPR Leafy Greens Market through Licensing Agreement
TeleTrader 14/05/2024 Bayer's sales in Q1 at €13.7 billion, down 4.3%
GlobeNewswire 02/05/2024 AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire 18/04/2024 AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire 16/04/2024 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire 11/04/2024 Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire 09/04/2024 AskBio Names Mansuo Shannon Chief Scientific Officer
GlobeNewswire 25/03/2024 BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire 14/03/2024 Bayer and Aignostics to collaborate on next generation precision oncology
GlobeNewswire 06/03/2024 BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
TeleTrader 05/03/2024 Bayer's Q4 sales at €11.9 billion
GlobeNewswire 04/03/2024 BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
TeleTrader 04/03/2024 Earnings preview: Bayer, Broadcom among those in calendar
GlobeNewswire 15/02/2024 2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust
GlobeNewswire 13/02/2024 Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
GlobeNewswire 13/02/2024 First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure